AI-generated summary
This protocol describes a planned randomised, double-blind trial testing whether photobiomodulation delivered by an LED boot can prevent diabetic foot ulcers in adults with type 2 diabetes at moderate to high risk. The authors report the planned design, with a PBM group and a sham group each receiving therapeutic education, and describe the assessments scheduled at 30 and 60 days. No results are reported in this protocol.
- Who or what was studied
- Adults aged 18 to 75 years of both sexes with type 2 diabetes mellitus at moderate to high risk of developing diabetic foot ulcer; planned 64 participants randomised into two groups of 32
- Wavelengths
- 660, 850 nm
- Limits stated in the abstract
- This is a study protocol with no results reported, so no findings on efficacy can be drawn from it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 850 nm
- Power
- 28.5 mW, 23 mW
- Total energy
- 10 J, 8 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Diabetic foot ulcer, Wavelength, Trial registration, Control group, Neuropathy, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.